The Network Biomedical Research Center for Cardiovascular Diseases (CIBERCV), dependent on the Carlos III Health Institute (ISCIII), has incorporated a group of excellence made up of researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and professionals from the Cardiology Service of the Bellvitge University Hospital (HUB). It has the collaboration of the ICS Primary Care and IMIM researchers.
The group linked to IDIBELL investigates personalized precision strategies for the interdisciplinary approach to heart failure in its evolutionary phases. Their research will contribute to the objective of the CIBERCV: reduce the impact of cardiovascular diseases and develop actions of excellence in translational cardiovascular research and training.
Led by Dr. Josep Comin, the head of the Cardiology Department of the HUB and the IDIBELL BioHeart research group, the team that forms part of the CIBERCV is made up of Laia Alcover, Esther Calero, Elena Calvo, Carlos Díez, Cristina Enjuanes, Alberto Garay, Elena Garcia Romero, Paloma Garcimartín, José González Costello, Santiago Jiménez, Oona Meroño, Pedro Moliner, Marta Tajes, José María Verdú, and Sergi Yun.
Thirteen new excellence groups have joined the CIBER to investigate cardiovascular diseases and other fields, such as biomaterials, respiratory and neurodegenerative diseases, obesity, public health, and oncology.
The Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center created in 2004. It is participated by the Bellvitge University Hospital and the Viladecans Hospital of the Catalan Institute of Health, the Catalan Institute of Oncology, the University of Barcelona and the City Council of L’Hospitalet de Llobregat.
IDIBELL is a member of the Campus of International Excellence of the University of Barcelona HUBc and is part of the CERCA institution of the Generalitat de Catalunya. In 2009 it became one of the first five Spanish research centers accredited as a health research institute by the Carlos III Health Institute. In addition, it is part of the “HR Excellence in Research” program of the European Union and is a member of EATRIS and REGIC. Since 2018, IDIBELL has been an Accredited Center of the AECC Scientific Foundation (FCAECC).